Cargando…
Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair
INTRODUCTION: In this study, we investigate the efficacy of repairing an osteochondral defect in rabbit knee joints by administering bevacizumab, a humanized monoclonal anti-vascular endothelial growth factor (VEGF) antibody. METHODS: An osteochondral defect was created on the patellar groove of 20...
Autores principales: | Nagai, Toshihiro, Sato, Masato, Kutsuna, Toshiharu, Kokubo, Mami, Ebihara, Goro, Ohta, Naoshi, Mochida, Joji |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991009/ https://www.ncbi.nlm.nih.gov/pubmed/20868495 http://dx.doi.org/10.1186/ar3142 |
Ejemplares similares
-
The properties of bioengineered chondrocyte sheets for cartilage regeneration
por: Mitani, Genya, et al.
Publicado: (2009) -
Measurement of diffusion in articular cartilage using fluorescence correlation spectroscopy
por: Lee, Jeong Ik, et al.
Publicado: (2011) -
Jellyfish mucin may have potential disease-modifying effects on osteoarthritis
por: Ohta, Naoshi, et al.
Publicado: (2009) -
Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis
por: Nagai, Toshihiro, et al.
Publicado: (2014) -
Human telomerase reverse transcriptase and glucose-regulated protein 78 increase the life span of articular chondrocytes and their repair potential
por: Sato, Masato, et al.
Publicado: (2012)